pISSN 2234-3806
eISSN 2234-3814

Fig. 2. Oncoprint of mutations detected in cfDNA at baseline. Columns depict patients; rows depict genes with mutation frequencies. A gene with multiple mutations was ranked as tier 1/2 when any of the mutations met the criteria for these tiers. Residual ctDNA post-chemotherapy is highlighted in yellow, and patients with pathogenic germline variants are indicated in dark gray.

Ann Lab Med 2025;45:199~208 https://doi.org/10.3343/alm.2024.0345